video thumbnail

COVID-19 and Sickle Cell, Thalassemia, and Hemophilia (Full Session)

Duration: 45:16

Write A New Comment

0 Comments

SARS-COV-2 and blood disorders

 

https://hemophilianewstoday.com/information-about-covid-19-for-hemophilia-patients/

 

What are inhibitors?

https://www.feiba.com/us/patient/hemophilia-inhibitors

For example factors VIII or IX clotting factors for hemophilia

 

 

Are patients with blood disorders at a higher risk?

Some patients with hemophilia may develop inhibitors and doctors may prescribe them immunosuppressants. These are medicines that suppress the immune system. They may, therefore, make patients more susceptible to infections including SARS-CoV-2.

 

 

Plasma therapy is safe from SARS-COV-2 pathogen transmission. Statement by HFA

https://www.hemophiliafed.org/news-stories/2020/03/plasma-protein-therapeutics-association-updated-statement-regarding-coronavirus/

 

PPTA Statement

https://www.pptaglobal.org/media-and-information/ppta-statements/1055-2019-novel-coronavirus-2019-ncov-and-plasma-protein-therapies

 

WORLD FEDERATION OF HEMOPHILIA RECOMMENDATIONS FOR HEMOPHILIA PATIENTS

https://www.hemophiliafed.org/news-stories/2020/03/world-federation-of-hemophilia-recommendations-for-hemophilia-patients/

 

Pandemic and hemoglobin disorders

Sickle cell anemia

Cell sickling in the hypoxic and acidic environment leading to the acute chest syndrome. Plus carboxyamide is mild immunosuppressant that may results in additional risk.

https://www.thalassemia.org/boduw/wp-content/uploads/2020/03/COVID-19-pandemic-and-haemoglobin-disorders_V2.pdf?__cf_chl_jschl_tk__=764a85856edbb5277a06a1c3c87ca9b7e0b49e6d-1589051509-0-Abe-j8o6Rzg3h049qyF_ddqkWDqhgebQLjG1o8390qmQu6_dFzpNjey2hVgV0BQa2RbQRVOBExkb9VdjMTT1bTg_zcvSbhOIZrh98-HkeIZW9jLyJOaUNTX-QVPrFoqJ8SCATKdUcLmnWRWyp2E5kU6n2GPg8fip_6XFf18uLY9fM2Ef45L65yjHhAyE_0aSTwF0B99q5Ivk0JV_WWZAGHZgp4vcbt_2IHqbinjwkUwxBw9D4zzGvdD7Npcc8nxL7ucH79x2BU_D8CXQ2kLMezf11xtbN4DrVQk-zl3XCcEn4jcwKtI6tKGRbcmcRqmgOsq_RrN8T2OEGQUxBhPtgv_ty6oNERuTgpapoO3nzjckPlFqE-UUuIdLLF13WfNxjQ

 

Hemophilia and COVID-19

von Willebrand Disease and Hemophilia A

https://news.wfh.org/world-federation-of-hemophilia-statement-update-to-covid-19/

 

 

Hypercoagulopathy

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156948/

 

Desmopressin (DDAVP)

https://en.wikipedia.org/wiki/Desmopressin

 

G6PD deficiency and COVID-19

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166036/

 

How I treat vWF disease

https://ashpublications.org/blood/article/97/7/1915/53343/How-I-treat-patients-with-von-Willebrand-disease

Following answers are created by ChatGPT. Occasionally the answer may be harmful, incorrect, false, misleading, incomplete, or limited in knowledge of world. Please contact your doctor for all healthcare decisions. Also, double check the answer provided by the AI below.

Please login to access this content.

Don't have an account?

See Plans

Instructors

Dr. Mobeen Syed

Dr. Mobeen Syed

MD., MSc., MSc., BSc

Mobeen Syed is the CEO of DrBeen Corp, a modern online medical education marketplace. Mobeen is a medical doctor and a software engineer. He graduated from the prestigious King Edward Medical University Lahore. He has been teaching medicine since 1994. Mobeen is also a software engineer and engineering leader. In this role, Mobeen has run teams consisting of hundreds of engineers and millions of dollars of budgets. Mobeen loves music, teaching, and doing business. He lives in Cupertino CA.

COVID-19

Related Videos